latest news releases from the newsroom
Ingen Technologies, Inc.
Ingen Restructures for Thermotex Acquisition
YUCAIPA, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a California-based medical device manufacturer announced today the new share restructure and trading symbols that will allow the company to complete two new acquisitions.
Talon Therapeutics, Inc.
Hana Biosciences to Report Fourth Quarter and Full Year 2008 Financial Results On March 31, 2009
SOUTH SAN FRANCISCO, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB) will announce its fourth quarter and full year 2008 results on Tuesday, March 31, 2009, after the close of the financial markets. Following the announcement, Hana Biosciences' management team will host a conference call that day at 5:00pm ET, 2:00pm PT to discuss results and highlights of the fourth quarter and full year 2008 and a business update.
Chelsea Therapeutics Reports Positive Results From Phase II Trial of CH-1504 in Rheumatoid Arthritis
CHARLOTTE, N.C., March 18, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that a preliminary analysis from its recently completed 12-week Phase II clinical trial in rheumatoid arthritis (RA) demonstrated that patients treated with once daily oral doses of CH-1504 at 0.25mg, 0.50mg and 1.0mg showed comparable ACR20/50/70 response rates to patients treated with a standard 20mg oral dose of methotrexate (MTX) administered once weekly. In addition, the efficacy of CH-1504 was associated with improved tolerability and reduced hepatotoxicty compared to the MTX.
Cardtronics Announces Departure of Its Chief Executive Officer
HOUSTON, March 18, 2009 (GLOBE NEWSWIRE) -- Cardtronics, Inc. (Nasdaq:CATM), the world's largest non-bank operator of ATMs, today announced that Jack M. Antonini, the Company's Chief Executive Officer, would be leaving the Company and its Board of Directors effective March 17, 2009. Fred R. Lummis, Chairman of the Company's Board, has agreed to serve as interim CEO while the Board conducts a formal search for Mr. Antonini's permanent successor.